Axogen Inc (STU:LT3)
€ 35.45 -2.67 (-7%) Market Cap: 1.89 Bil Enterprise Value: 1.82 Bil PE Ratio: 0 PB Ratio: 8.81 GF Score: 70/100

AxoGen Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2026 / 06:30PM GMT
Release Date Price: €26.8 (+1.52%)
Unidentified Participant 1

Good morning, everyone. Welcome, and thank you for joining us. My name is [Doug Gibermedan]. I'm an associate in the health care group at JPMorgan. And today, I have the pleasure of introducing the Axogen team. Joining us today is President and CEO, Mike Dale; and we also have CFO, Lindsey Hartley with us.

Just a quick reminder on format. This will be a 20-minute presentation followed by 20 minutes of Q&A. Before we start, just be advised that there will be a handheld mic being passed around during Q&A.

Thank you, and I'll pass it over to Mike.

Michael Dale
AxoGen Inc - Chief Executive Officer, Director

Well, thank you genuinely, thank you to JPMorgan for the opportunity to share Axogen's story. I have the privilege of leading this business now for a little over 1.5 years, and I'll look forward to sharing with each of you what we believe to be the opportunity and the purposes behind Axogen and what that means to all stakeholders.

It's always important, of course, to start with what is the purpose of your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot